Works matching DE "PROGRESSION-free survival"

Results: 5000
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Durvalumab Alone or Combined With Novel Agents for Unresectable Stage III Non–Small Cell Lung Cancer: Update From the COAST Randomized Clinical Trial.

    Published in:
    JAMA Network Open, 2025, v. 8, n. 7, p. e2518440, doi. 10.1001/jamanetworkopen.2025.18440
    By:
    • Aggarwal, Charu;
    • Martinez-Marti, Alex;
    • Majem, Margarita;
    • Barlesi, Fabrice;
    • Carcereny, Enric;
    • Chu, Quincy;
    • Monnet, Isabelle;
    • Sánchez-Hernández, Alfredo;
    • Dakhil, Shaker;
    • Camidge, D. Ross;
    • Pillet, Marine;
    • Brown, Miranda;
    • Paliompeis, Christos;
    • Dowson, Adam;
    • Cooper, Zachary A.;
    • Kumar, Rakesh;
    • Herbst, Roy S.
    Publication type:
    Article
    12

    Transarterial chemoembolization combined with apatinib in the treatment of advanced hepatocellular carcinoma: a prospective, multi-center, real-world study (Ahend-HAP02).

    Published in:
    Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1615911
    By:
    • Yuan, Hang;
    • Li, Zhen;
    • Cao, Guang-Shao;
    • Xu, Fei;
    • Wu, Gang;
    • Ding, Peng-Xu;
    • Wei, Qiu-Liang;
    • Chang, Zu-Kuan;
    • Xing, Cheng;
    • Niu, Huan-Zhang;
    • Yin, Jun;
    • Yao, Quan-Jun;
    • Zheng, Lin;
    • Xiao, Jin-Cheng;
    • Chen, Cheng-Shi;
    • Cheng, Hong-Tao;
    • Zong, Deng-Wei;
    • Xia, Wei-Li;
    • Geng, Xiang;
    • Zhao, Xiao-Hui
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24

    The Usefulness of the Modified Advanced Lung Cancer Inflammation Index (mALI) as a Prognostic Factor in Patients With Esophageal Cancer who Have Undergone Curative Resection.

    Published in:
    In Vivo, 2025, v. 39, n. 4, p. 2176, doi. 10.21873/invivo.14013
    By:
    • SOSUKE YAMAMOTO;
    • TORU AOYAMA;
    • YUKIO MAEZAWA;
    • ITARU HASHIMOTO;
    • RYUKI ESASHI;
    • KAZUKI OTANI;
    • SUGURU NUKADA;
    • TETSUSHI ISHIGURO;
    • KIYOKO SHIMADA;
    • KEISUKE KAZAMA;
    • KOJI NUMATA;
    • MAMORU UCHIYAMA;
    • REI HATAYAMA;
    • AYAKO TAMAGAWA;
    • AYA SAITO;
    • NORIO YUKAWA
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Exploring IDH1 and IDH2 Mutations in Paediatric Medulloblastoma.

    Published in:
    Folia Biologica (00155500), 2025, v. 71, n. 2, p. 73, doi. 10.14712/fb2025071020073
    By:
    • FADUL, MOTAZ;
    • BAEESA, SALEH;
    • ALKHOTANI, ALAA;
    • FATHADDIN, AMANY A.;
    • LARY, AHMED I.;
    • ADDASS, BASSAM;
    • ALSINANI, TAGHREED;
    • BAMAGA, AHMED;
    • ALBESHRI, AHMAD;
    • KARAMI, MOHAMMED M.;
    • ABUTALIB, MOHAMMED A.;
    • KURDI, MAHER
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Prognostic impact of second surgical resection in IDH wildtype recurrent glioblastoma following chemo-radiation therapy: a propensity score analysis cohort study.

    Published in:
    Journal of Neuro-Oncology, 2025, v. 174, n. 3, p. 789, doi. 10.1007/s11060-025-05096-9
    By:
    • Bertolini, Giacomo;
    • Trombini, Tommaso;
    • Zenesini, Corrado;
    • Mazza, Stefania;
    • Dascola, Isabella;
    • Pavarani, Antonio;
    • Michiara, Maria;
    • Ceccon, Giovanni;
    • Peluso, Andrea;
    • Calamo Specchia, Francesco Maria;
    • Crafa, Pellegrino;
    • Menozzi, Roberto;
    • Giombelli, Ermanno
    Publication type:
    Article
    43
    44
    45
    46

    Outcomes of teclistamab in patients with relapsed/refractory multiple myeloma with prior exposure to BCMA-directed therapy: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01314-9
    By:
    • Dima, Danai;
    • Vazquez-Martinez, Mariola A.;
    • Davis, James A.;
    • Goel, Utkarsh;
    • Afrough, Aimaz;
    • Sannareddy, Aishwarya;
    • Pasvolsky, Oren;
    • Razzo, Beatrice;
    • Banerjee, Rahul;
    • Khouri, Jack;
    • Grajales-Cruz, Ariel;
    • Lieberman-Cribbin, Alex;
    • Rana, Masooma Shifa;
    • Julian, Kelley;
    • DeJarnette, Shaun;
    • Portuguese, Andrew J.;
    • Gaballa, Mahmoud R.;
    • De Avila, Gabriel;
    • Susaniba Adaniya, Sandra;
    • Raza, Shahzad
    Publication type:
    Article
    47
    48
    49

    Adjuvant Pembrolizumab after Upfront Multimodal Therapy for Stage IVB Anaplastic Thyroid Cancer.

    Published in:
    Thyroid, 2025, v. 35, n. 7, p. 763, doi. 10.1089/thy.2025.0194
    By:
    • Cabanillas, Maria E.;
    • Busaidy, Naifa L.;
    • Gunn, G. Brandon;
    • Iyer, Priyanka C.;
    • Ferrarotto, Renata;
    • Gule-Monroe, Maria;
    • Maniakas, Anastasios;
    • Williams, Michelle D.;
    • Liu, Suyu;
    • Fellman, Bryan;
    • Spiotto, Michael;
    • Hamidi, Sarah;
    • Akhave, Neal;
    • Lee, Anna;
    • Wang, Jennifer R.;
    • de Sousa, Luana;
    • Marczyk, Vicente R.;
    • Zafereo, Mark;
    • Dadu, Ramona
    Publication type:
    Article
    50